MPM Bioventures 2018, L.P.'s Form 4 filing
Entrada Therapeutics, Inc. (TRDA) · filed Sep 3, 2026
- Accession no.
- 0001231919-26-001144
- Filed
- Sep 3, 2026, 7:21 PM ET
- Trade date
- Sep 1-3, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $617.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| MPM Bioventures 2018, L.P.CIK 0001729505 | 10% Owner |
| MPM BioVentures 2018 GP LLCCIK 0001818701 | 10% Owner |
| MPM BioVentures 2018 LLCCIK 0001818702 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | SSaleDisposed | −29,088 | $7.06 | −$205,361.28 | 4,202,346 | Indirect | Duplicate filing |
| Sep 2, 2026 | Common Stock | SSaleDisposed | −25,131 | $7.19 | −$180,691.89 | 4,177,215 | Indirect | Duplicate filing |
| Sep 3, 2026 | Common Stock | SSaleDisposed | −32,263 | $7.17 | −$231,325.71 | 4,144,952 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.